Anxiety Disorder and Depression Treatment Market To Reach USD 18.90 Billion By 2026
Market Summary The rise in the graying population and minimal side effects associated with the treatment are some of the factors boosting the market for Anxiety Disorder and Depression Treatment. Market Size – USD 15.60 Billion in 2018, Market Growth - CAGR of 2.4%, Market Trends – Increase in awareness regarding mental health. The Global Anxiety Disorder and Depression Treatment Market is forecast to reach USD18.90 Billion by 2026, according to a new report by Reports and Data. There has been a continued rise in the rate of depression and anxiety in the global healthcare scenario. Such a rise in the incidence rate of depression and anxiety has resulted in focusing on the global healthcare scenario and reduce the incidence rate of such mental healthcare condition. Further key findings from the report suggest : • The rising rate of occurrence of depression and anxiety is one of the contributing factors for the high consumption rate of anti-depressants. • This rise in the occurrence rate of anxiety and depression is one of the major driving factors for global Anxiety Disorder and Depression Treatment Market, contributing to market growth. www.reportsanddata.com
Key Players: Johnson & Johnson, Inc., Pfizer, GlaxoSmithKline plc., Lundbeck A/S, Inc., Sanofi- Aventis, Merck & Company, AstraZeneca PLC., Forest Laboratories, Eli Lilly and Company, Bristol-Myers Squibb Company among Segmentation: • Drug class Outlook (Revenue, USD Billion; 2016-2026), Selective Serotonin Reuptake Inhibitors (SSRIs), Antidepressant Drugs, Tricyclic Antidepressants (TCAs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), Monoamine Oxidase Inhibitors (MAOIs), Benzodiazepines, Atypical Antipsychotics, Anticonvulsants, Beta-Blockers, Others • Therapies Outlook (Revenue, USD Billion; 2016-2026), Electroconvulsive Therapy (ECT), Cognitive Behavior Therapy (CBT), Psychotherapy, Deep Brain Stimulation, Transcranial Magnetic Stimulation (TMS), Cranial electrotherapy stimulation (CES),Devices Outlook (Revenue, USD Billion; 2016-2026), Cranial electrotherapy stimulator, Fisher-Wallace stimulator market • Application Outlook (Revenue, USD Billion; 2016-2026), Phobia, Major Depressive Disorder, Obsessive Compulsive Disorder (OCD), Post-traumatic stress disorder, Others • End-users Outlook (Revenue, USD Billion; 2016-2026), Hospitals, Mental healthcare centers, NGOs, Asylums www.reportsanddata.com
Regional Anxiety Disorder and Depression Treatment Market (Regional Output, Demand & Forecast by Countries):• North America (United States, Canada, Mexico) • South America (Brazil, Argentina, Ecuador, Chile) • Asia Pacific (China, Japan, India, Korea) • Europe (Germany, UK, France, Italy) • Middle East Africa (Egypt, Turkey, Saudi Arabia, Iran) and More.
www.reportsanddata.com
Major highlights of the report: • An all-inclusive evaluation of the parent market • The evolution of significant market aspects • Industry-wide investigation of market segments • Assessment of the market value and volume in the past, present and forecast years • Market share evaluation • Study of niche industrial sectors • Tactical approaches of the market leaders • Lucrative strategies to help companies strengthen their position in the market
www.reportsanddata.com
About Us:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com